On March 3, 2022, Jeff Goater informed Vaccinex, Inc. that due to new responsibilities and conflicting demands on his time, he will not stand for re-election as a director at the Company's 2022 annual meeting of stockholders.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
5.44 USD | -2.67% | -1.74% | -41.55% |
05-16 | Earnings Flash (VCNX) VACCINEX Reports Q1 Revenue $104,000 | MT |
04-12 | Vaccinex, Inc. announced that it has received $1.75 million in funding | CI |
- Stock Market
- Equities
- VCNX Stock
- News VACCINEXPAR
- Jeff Goater Not to Stand for Re-Election as a Director of Vaccinex, Inc